Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

UGT1A1 and Phase 2 Detoxification: What Your Genes Mean for Toxin Clearance

Phase 2 detoxification is a key step in how your body neutralizes and removes potentially harmful compounds. After Phase 1 partially modifies a toxin, Phase 2 attaches a small molecule to it to make it water soluble so it can be excreted. The UGT1A1 gene encodes an enzyme that carries out glucuronidation, a major Phase 2 reaction. This enzyme helps clear substances such as bilirubin, alcohol metabolites, bisphenol A or BPA, some mold toxins, and a variety of environmental chemicals.

Genetic differences in UGT1A1 can change how effectively your body performs glucuronidation. Variants at rs4148323 influence enzyme activity and therefore how quickly certain toxins are removed. Below is an approachable explanation of what each genotype means for your detox capacity and practical ways to support the body if your genetics suggest reduced activity.

How reduced UGT1A1 activity can affect health

  • Slower glucuronidation may allow certain toxins to stay in circulation longer, increasing overall toxic burden.
  • Compounds affected include BPA, bilirubin, alcohol breakdown products, some mycotoxins, and lipid peroxides.
  • Over time higher toxin exposure or impaired clearance may contribute to oxidative stress, inflammation, or sensitivity to environmental chemicals.
  • Knowing your UGT1A1 genotype can help you tailor diet, lifestyle, and other strategies to reduce exposure and support detox pathways.

General lifestyle and diet strategies to support glucuronidation

Whether your genotype indicates reduced or typical UGT1A1 activity, the following steps help support Phase 2 detoxification and overall resilience to environmental toxins.

  • Eat cruciferous vegetables regularly. Broccoli, cauliflower, Brussels sprouts, kale, and bok choy contain compounds that support detox enzymes.
  • Include berries and colorful fruits. Flavonoids and polyphenols found in berries support antioxidant defenses and liver pathways.
  • Prioritize leafy greens. Spinach, Swiss chard, and other greens provide vitamins and phytonutrients that support liver function.
  • Limit alcohol intake. Alcohol increases liver workload and produces reactive metabolites that need detoxification.
  • Avoid BPA and other endocrine disruptors. Use glass or stainless steel containers, avoid heating plastics, and choose fresh foods over canned goods when possible.
  • Minimize exposure to moldy foods and rancid oils. Mold toxins and oxidized fats add to toxic burden and stress detox pathways.
  • Focus on gut health. A balanced microbiome supports enterohepatic circulation and elimination. Include fiber, fermented foods, and avoid unnecessary antibiotics.
  • Stay hydrated. Adequate water intake supports kidney filtration and elimination of water soluble conjugates created by glucuronidation.
  • Exercise regularly. Physical activity supports circulation, lymphatic flow, and metabolic health.
  • Optimize vitamin D status. Vitamin D supports immune function and may indirectly aid detox resilience. Test levels and supplement to achieve adequate status under provider guidance.

Dietary and supplement considerations

  • Increase cruciferous vegetable intake to provide glucosinolate derivatives that support Phase 2 enzymes.
  • Consume foods rich in flavonoids such as onions, citrus, tea, and berries. Flavonoids can modulate detox enzymes and protect against oxidative damage.
  • Consider targeted supplements if recommended by your healthcare provider: flavonoid complexes, vitamin D if deficient, and other liver-support nutrients such as milk thistle or N acetylcysteine when appropriate.
  • Prioritize a fiber rich diet to support bile acid binding and elimination of conjugated toxins.

Genetic interpretations

2 effect alleles (AA at rs4148323): Reduced UGT1A1 activity

If you have the AA genotype, you carry two copies of the effect allele. This is associated with reduced UGT1A1 enzyme activity and a lower glucuronidation capacity. Toxins that rely on glucuronidation for removal may be cleared more slowly. Substances of particular relevance include:

  • Bilirubin. Reduced clearance can increase bilirubin levels in some contexts.
  • Alcohol metabolites. Slower processing of reactive alcohol byproducts may increase oxidative stress.
  • BPA and other environmental phenols. Prolonged exposure can increase body burden.
  • Mold related toxins and certain lipid peroxides that undergo glucuronidation.

Support strategies for AA genotype:

  • Increase cruciferous vegetables and fiber to help drive Phase 2 pathways and promote elimination.
  • Limit alcohol and avoid high exposure to BPA, rancid oils, and moldy foods.
  • Work with your healthcare provider to assess vitamin D status and consider supplementation if low.
  • Consider antioxidant and flavonoid support under medical guidance to protect against oxidative stress.
  • Monitor liver health and relevant labs with your clinician if you have symptoms or other risk factors.
1 effect allele (AG at rs4148323): Slightly reduced UGT1A1 activity

If you have the AG genotype, you carry one copy of the effect allele. This is associated with a modest decrease in UGT1A1 activity compared with those who carry two non effect alleles. Your glucuronidation capacity may be somewhat less efficient, which could allow certain toxins to be cleared more slowly.

Support strategies for AG genotype:

  • Adopt many of the same dietary and lifestyle measures recommended for reduced activity: cruciferous vegetables, berries, leafy greens, and fiber.
  • Limit alcohol and minimize exposures to BPA, moldy foods, and oxidized oils.
  • Encourage gut health through prebiotics, probiotics, and regular bowel habits to support elimination.
  • Consider discussing supplements such as flavonoid complexes or vitamin D with your healthcare provider if clinically appropriate.
0 effect alleles (GG at rs4148323): Typical UGT1A1 activity

If you have the GG genotype, you carry two copies of the non effect allele. This corresponds to typical UGT1A1 enzyme activity and normal glucuronidation function. Your body is generally effective at attaching glucuronic acid to toxins for water soluble elimination, helping to process compounds such as BPA, bilirubin, alcohol metabolites, and various environmental toxins.

Recommendations for GG genotype:

  • Maintain a balanced, nutrient dense diet that includes cruciferous and leafy vegetables, berries, and adequate fiber to support liver function.
  • Continue to minimize unnecessary exposures to alcohol, BPA, mold, and oxidized oils to preserve detox capacity.
  • Stay active, hydrated, and attentive to gut health to support ongoing elimination efficiency.

When to talk to your healthcare provider

  • If you have symptoms such as persistent unexplained fatigue, jaundice, or other signs of liver dysfunction.
  • If you are considering high dose supplements or drastic detox protocols.
  • If you have occupational or high environmental exposures to toxins and want a tailored plan.
  • When you want lab testing to assess liver function, bilirubin, vitamin D status, or other relevant markers.

PlexusDx provides educational information about genetic predispositions only. This content is not medical advice. Always consult your healthcare provider before making changes to your diet, supplement routine, or medical care based on genetic information.

If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:

🧬 Genetic Tests:

🧪 Blood Tests:

📄 Genetic Report:

Frequently Asked Questions About PHASE 2 DETOX and UGT1A1 rs4148323

What does the UGT1A1 rs4148323 variant mean for Phase 2 detoxification?

UGT1A1 controls glucuronidation, a major Phase 2 detox step that attaches glucuronic acid to compounds so they can be excreted. Differences at rs4148323 can change how efficiently your body performs glucuronidation, potentially affecting clearance of substances such as bilirubin, alcohol metabolites, BPA, some mold toxins, and other environmental chemicals.

How do the UGT1A1 rs4148323 genotypes (AA, AG, GG) differ in detox capacity?

AA (2 effect alleles) is linked to reduced UGT1A1 activity and lower glucuronidation capacity, which may slow removal of certain toxins. AG (1 effect allele) typically suggests a modest decrease in activity and somewhat less efficient clearance. GG (0 effect alleles) corresponds to typical UGT1A1 activity and generally normal glucuronidation function, supporting normal processing and elimination of glucuronidation-reliant compounds.

What lifestyle and diet strategies can support glucuronidation if my UGT1A1 activity is reduced?

To support Phase 2 detoxification, focus on regular cruciferous vegetables (broccoli, kale, bok choy), fiber-rich foods, leafy greens, and antioxidant-rich fruits/berries. Limit alcohol, reduce exposure to BPA and other endocrine disruptors (e.g., avoid heating plastics; choose fresh foods over canned when possible), and minimize moldy foods and rancid/oxidized oils. Also prioritize gut health (fiber, fermented foods, healthy bowel habits), hydration, regular exercise, and—if needed—vitamin D optimization based on clinician guidance.

What tests can help me learn more about PHASE 2 DETOX and UGT1A1 rs4148323?

The Functional Health Genetic Test delivers over 750 personalized genetic insights across 10 in-depth genetic reports to support whole-body, systems-level health understanding. The Detoxification Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.